Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Mark_Kotter
|
| gptkbp:collaboratesWith |
gptkb:Charles_River_Laboratories
National Institute for Health and Care Research (NIHR) |
| gptkbp:developedBy |
human cells for research and therapy
|
| gptkbp:focusesOn |
synthetic biology
cell reprogramming gene therapy |
| gptkbp:foundedBy |
gptkb:Mark_Kotter
|
| gptkbp:foundedIn |
2016
|
| gptkbp:fundedBy |
gptkb:Foresite_Capital
gptkb:Arch_Venture_Partners gptkb:Tencent gptkb:Charles_River_Laboratories National Institute for Health and Care Research (NIHR) |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
bit.bio
|
| gptkbp:mission |
coding cells for health
|
| gptkbp:offersProduct |
gptkb:ioCells
ioGlutamatergic Neurons ioMicroglia ioSkeletal Myocytes |
| gptkbp:technology |
optio-genetics
precision reprogramming |
| gptkbp:website |
https://www.bit.bio/
|
| gptkbp:bfsParent |
gptkb:Mark_Kotter
|
| gptkbp:bfsLayer |
7
|